September 15, 2026

Panther Life Sciences

Hanana

Mounir Hanana, who most recently served as CFO of Amazon Business in Seattle, has been named CEO of New York's Panther Life Sciences, a company building a needle-free alternative to injections.

Panther Life Sciences founder Carlos Bhola will continue as executive chairman, partnering closely with Hanana as Panther commercializes its SmartPatch platform across high-growth health, wellness and therapeutic markets, including dermatology and aesthetic applications.

“We were intentional in our search for a partner with a track record of deploying global technology platforms, scaling manufacturing, and commercializing innovation — and we found that in Mounir,” said Bhola in a release. “I am excited by what Panther will accomplish under Mounir's direction and am looking forward to closely partnering with him.”

Hanana brings 25 years of global leadership experience across Procter & Gamble and Amazon. During his career, he has led initiatives ranging from several hundred million dollars in revenue to large global multibillion-dollar businesses, combining expertise in manufacturing, commercialization, technology platforms and operational scale.

At Procter & Gamble, he helped bring consumer products from development to market through world-class manufacturing, supply chains and commercial organizations. At Amazon, he led large global technology businesses. Together, these experiences span consumer products, advanced manufacturing, global technology platforms and operational excellence—capabilities critical for Panther's next phase of commercialization.

“Having spent much of my career building and scaling global businesses, I know a category-defining opportunity when I see one,” said Hanana. “That is why I joined Panther. Our team has built a unique, powerful technology capable of transforming both consumer and medical markets.”